|
|
| | GSK121 (trifluoroacetate salt) Basic information |
| Product Name: | GSK121 (trifluoroacetate salt) | | Synonyms: | GSK121 (trifluoroacetate salt);(3-Amino-1-piperidinyl)[1-methyl-2-(1-methyl-1H-indol-2-yl)-1H-benzimidazol-5-yl]-methanone TFA Salt;GSK121 trifluoroacetate;GSK121;(3-Amino-1-piperidinyl)[1-methyl-2-(1-methyl-1H-indol-2-yl)-1H-benzimidazol-5-yl]-methanone Trifluoroacetic Acid Salt;(3-aminopiperidin-1-yl)-[1-methyl-2-(1-methylindol-2-yl)benzimidazol-5-yl]methanone;Protein Arginine Deiminase,GSK121,inhibit,Peptidylarginine Deiminase,Inhibitor | | CAS: | 1652591-80-4 | | MF: | C25H26F3N5O3 | | MW: | 501.51 | | EINECS: | | | Product Categories: | | | Mol File: | 1652591-80-4.mol |  |
| | GSK121 (trifluoroacetate salt) Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: 30 mg/ml; PBS (pH 7.2): 10 mg/ml | | form | A crystalline solid | | color | Light brown to brown |
| | GSK121 (trifluoroacetate salt) Usage And Synthesis |
| Uses | (3-Amino-1-piperidinyl)[1-methyl-2-(1-methyl-1H-indol-2-yl)-1H-benzimidazol-5-yl]-methanone Trifluoroacetic Acid Salt is an inhibitor for protein arginine deiminase 4 (PAD4), which has been implicated in the pathogenesis of autoimmune and cardiovascular diseases. |
| | GSK121 (trifluoroacetate salt) Preparation Products And Raw materials |
|